During the third episode of BrainSplain, your host, Kaitlyn Rarick connects with the Founder and CEO of NeuroMetrix, Shai Gozani M.D., Ph.D. Electroceuticals are a new type of therapeutic agents that work by mapping neural circuitry and delivering neural impulses to these specific targets. Listen to find out more about the impact and future of electroceuticals. 

Shai Gozani Short Bio

Shai Gozani, founded NeuroMetrix, Inc. in 1996 as a spin-off from the Massachusetts Institute of Technology. He currently serves as Chairman of the board of directors and as our President and Chief Executive Officer. Shai has led the Company from a venture capital backed start-up, through an initial public offering on Nasdaq, through development of a successful diagnostics business, and presently into the wearable technology sector. Over 2.5 million patients have benefited from the Company’s technology over the past 17 years.

Shai has published over 30 peer-reviewed scientific articles and has been awarded 25 US and international patents. He holds a B.A. degree in Computer Science, a M.S. degree in Electrical Engineering & Computer Science (Biomedical Engineering Focus) and a Ph.D. in Neurobiology, from the University of California, Berkeley. Shai also received an M.D. from Harvard Medical School and the Harvard-MIT Division of Health Sciences and Technology at M.I.T.

Links

NeuroMetrix Website

Quell Relief Website

Kaitlyn Rarick LinkedIn